COVID 19 News and Research

RSS

An Interview with The Million Veteran Program (MVP)

In this interview, we speak to Dr. Sumitra Muralidhar, the Program Director for VA’s Million Veteran Program (MVP) about the program and its aims for veterans.

28 Jan 2022

Novel study to identify how immune receptors recognize unique chemical signals on fungal cells

A new study tries to pinpoint the crucial first step in how human immune systems recognize fungal invaders.

From University of Exeter 27 Jan 2022

Omicron variant inefficient in causing diseases than other COVID-19 variants, study reveals

Scientists from the Department of Microbiology at the University of Hong Kong (HK) have found that the Omicron variant of SARS-CoV-2 replicates less efficiently and causes fewer diseases than other variants of COVID19.

27 Jan 2022

Culturing marine sponge cells in 3D could scale-up production of biomass, bioactive metabolites

There are more than 9,000 species of marine sponges (Phylum Porifera) worldwide, which are a source of novel natural products.

25 Jan 2022

Omicron variant found to be less effective at blocking cellular defense mechanism against viruses

A new study by researchers from the University of Kent and the Goethe University Frankfurt shows that the SARS-CoV-2 Omicron variant is less effective than Delta at blocking a cellular defense mechanism against viruses, the so-called “interferon response”.

25 Jan 2022

COVID-19 vaccines prompt the body to make long-lasting T cells against different variants

Scientists at La Jolla Institute for Immunology (LJI) have found that four COVID-19 vaccines (Pfizer-BioNTech, Moderna, J&J/Janssen, and Novavax) prompt the body to make effective, long-lasting T cells against SARS-CoV-2.

25 Jan 2022

Producing New Antibiotics Through Gene Editing

In this interview, we speak to Professor Jason Micklefield about his latest research that may be able to produce new antibiotics through gene-editing technologies.

From The University of Manchester 24 Jan 2022

Researchers use cryo-EM to rapidly characterize antibodies at atomic level

Scripps Research scientists have found a mechanism that may be able to bypass one of the critical steps in current vaccine production.

24 Jan 2022

Study highlights incomplete and inconsistent nutrition information provided by online food retailers

Online food retailers do not consistently display nutrition information on their websites-;and U.S. laws are lagging behind in mandating the same labeling required for foods sold in brick-and-mortar stores, according to a new analysis by researchers from the NYU School of Global Public Health and the Friedman School of Nutrition Science and Policy at Tufts University.

From New York University (NYU) 21 Jan 2022

Memory T cells formed after prior infection or vaccination respond to omicron variant

The omicron variant can partly evade the antibody response provided by vaccination or infection with previous variants of SARS-CoV-2.

20 Jan 2022

Study identifies respiratory syncytial viral protein that mediates RSV-induced autophagy

A viral protein might contain information that could be used to avoid pneumonia due to the body’s overactive response to respiratory viruses, such as COVID-19.

20 Jan 2022

Study analyzes the global patterns of access to digital sequence information

The United Nations Convention on Biological Diversity recognized the rights of nations over their ecosystems’ diversity, which comprises all non-human living creatures.

20 Jan 2022

Non-neutralizing antibodies likely to protect against COVID, says study

Non-neutralizing antibodies may also be crucial in giving protection against COVID-19, according to a recent study from Lund University in Sweden.

20 Jan 2022

Virologists identify a dual-action drug effective against SARS-CoV-2

A research team discovered a new dual attack mode of action while working on the development of a therapeutic candidate against SARS-CoV-2 infections.

20 Jan 2022

Researchers discover a gene variant that protects against severe COVID-19 infection

An international metastudy led by researchers at Karolinska Institute in Sweden has identified a specific gene variant that protects against severe COVID-19 infection.

17 Jan 2022

Researchers identify new potential drug target that may block SARS-CoV-2 infection

In the quest for new treatments for COVID-19, a team led by researchers at UC San Francisco has identified a new potential drug target that may block infection by SARS-CoV-2. The protein, called BRD2, regulates the ACE2 receptor, which the novel coronavirus relies on to gain entry to its host's cells.

17 Jan 2022

Synthetic antibody demonstrates Omicron detection along with all other variants of concern

MIP Diagnostics Ltd. has today announced that its synthetic SARS-CoV-2 antibody (COVID-19 nanoMIPTM) can detect the Omicron variant as well as previously proven Alpha, Beta, Delta and Gamma variants of the COVID-19 virus.

14 Jan 2022

Research sheds new insights into development of lung macrophages in humans

The lungs are exposed to microorganisms like viruses and bacteria from the moment of the first breath.

13 Jan 2022

Study analyzes the impact of T cells from common cold coronaviruses against SARS-CoV-2 exposure

A new study has illustrated that people having higher levels of T cells from common cold coronaviruses are not likely to get infected with SARS-CoV-2.

13 Jan 2022

Researchers determine how key protein drives the defense system to fight viruses

Scientists have just found a solution to a major mystery that explains how human blood cells train the defense system against viruses. They hope that this discovery will one day allow them to better control the response and either boost or calm it as needed.

13 Jan 2022

COVID 19 News and Research

An Interview with The Million Veteran Program (MVP)

Novel study to identify how immune receptors recognize unique chemical signals on fungal cells

Omicron variant inefficient in causing diseases than other COVID-19 variants, study reveals

Culturing marine sponge cells in 3D could scale-up production of biomass, bioactive metabolites

Omicron variant found to be less effective at blocking cellular defense mechanism against viruses

COVID-19 vaccines prompt the body to make long-lasting T cells against different variants

Producing New Antibiotics Through Gene Editing

Researchers use cryo-EM to rapidly characterize antibodies at atomic level

Study highlights incomplete and inconsistent nutrition information provided by online food retailers

Memory T cells formed after prior infection or vaccination respond to omicron variant

Study identifies respiratory syncytial viral protein that mediates RSV-induced autophagy

Study analyzes the global patterns of access to digital sequence information

Non-neutralizing antibodies likely to protect against COVID, says study

Virologists identify a dual-action drug effective against SARS-CoV-2

Researchers discover a gene variant that protects against severe COVID-19 infection

Researchers identify new potential drug target that may block SARS-CoV-2 infection

Synthetic antibody demonstrates Omicron detection along with all other variants of concern

Research sheds new insights into development of lung macrophages in humans

Study analyzes the impact of T cells from common cold coronaviruses against SARS-CoV-2 exposure

Researchers determine how key protein drives the defense system to fight viruses

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics